Sökning: "NSCLC"
Visar resultat 36 - 40 av 46 avhandlingar innehållade ordet NSCLC.
36. Targeting Gb3 and apoptosis-related proteins to overcome cisplatin resistance
Sammanfattning : Background Cisplatin is used for treatment of malignant pleural mesothelioma (MPM) and non-small cell lung cancer (NSCLC) but treatment with cisplatin often leads to acquired resistance to cisplatin, resulting in poor patient survival. Globotriaosylceramide (Gb3) and multidrug resistance protein 1 (MDR1) have been associated with cisplatin resistance. LÄS MER
37. Nuclear medicine imaging of lung cancer and esophagus cancer
Sammanfattning : Background: Somatostatin receptors (SSTRs) occur in cancer tissue, and 99mTc-depreotide is a labelled somatostatin receptor analogue, binding to SSTRs subtype 2, 3, and 5. Purpose: The general aim of the present thesis was to study somatostatin receptor scintigraphy (SSTRS) with 99mTc-depreotide in the diagnosis and characterization of cancers in the lung and oesophagus. LÄS MER
38. Studies of cell migration and matrix protease production in human lung cancer cell lines
Sammanfattning : Metastatic spread in cancer is a complex multistep process involving continuous, sequential interactions between tumour cells and their respective microenvironment. Invasiveness per se has not been studied in this thesis, only some of its major components, such as cell migration and matrix protease production. LÄS MER
39. Molecular characterization of estrogen receptor beta variants : cancer cell proliferation and invasion
Sammanfattning : Estrogen plays crucial roles in the pathogenesis of breast cancer. Most of the known effects of estrogen signaling are mediated by estrogen receptors (ERs), ERα and ERβ. ERα is explored for breast cancer molecular classification and is a target of endocrine therapy. LÄS MER
40. At the intersection of proteomics and pathology : application of mass spectrometry-based protein quantification to histopathology and antibody validation
Sammanfattning : The paradigm of Precision Medicine relies on the molecular stratification of patients to select “the right patient for the right drug”. The genomic approach has tried to answer this question, but large genomic studies have raised more questions than given answers. LÄS MER